Page 9 - Small Cap U.S. Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
GDTC CytoMed Therapeutics	US$2.31	4.5%	-36.6%	US$25.7m	US$5.00	PS79.8x	E10.2%	n/a
SABS SAB Biotherapeutics	US$2.95	-3.6%	-66.1%	US$27.4m	US$12.40	PS18x	E-16.6%	n/a
EQ Equillium	US$0.77	7.2%	48.6%	US$27.6m	US$3.33	PB1.2x	E-28.2%	n/a
DARE Daré Bioscience	US$3.30	3.8%	-21.4%	US$27.7m	US$21.33	PS15.3x	E71.4%	n/a
HOOK HOOKIPA Pharma	US$2.48	-8.8%	-54.9%	US$28.0m	US$38.75	PB0.4x	E8.8%	n/a
AKTX Akari Therapeutics	US$1.12	-23.8%	-62.4%	US$28.2m	n/a	PE-1.4x	n/a	n/a
INKT MiNK Therapeutics	US$0.72	2.2%	-29.4%	US$28.6m	US$6.67	PE-2.1x	E45.3%	n/a
DRRX DURECT	US$0.91	1.0%	40.4%	US$29.1m	US$6.75	PS3.3x	E65.0%	n/a
MRKR Marker Therapeutics	US$3.19	0.3%	10.0%	US$29.1m	US$19.00	PS5.3x	E-38.9%	n/a
IGC IGC Pharma	US$0.37	12.2%	18.8%	US$29.2m	US$3.63	PS24.5x	E0.1%	n/a
LGVN Longeveron	US$2.06	11.4%	-89.4%	US$29.7m	US$8.50	PS16.5x	E50.2%	n/a
KALA KALA BIO	US$6.65	3.4%	16.5%	US$29.9m	US$15.00	PB4.5x	E-11.3%	n/a
CMMB Chemomab Therapeutics	US$1.78	8.5%	218.0%	US$30.0m	US$8.00	PB2.1x	E-16.2%	n/a
PLUR Pluri	US$5.57	10.1%	12.8%	US$30.0m	n/a	PS51.8x	n/a	n/a
ANGN Angion Biomedica	US$1.00	17.7%	-37.9%	US$30.1m	n/a	PS46.1x	S-122.1%	n/a
ALTS ALT5 Sigma	US$2.26	3.2%	426.8%	US$30.2m	n/a	PS4.5x	n/a	n/a
ISO IsoPlexis	US$0.76	0.07%	-80.6%	US$30.3m	US$1.70	PS1.8x	E43.9%	n/a
SRZN Surrozen	US$10.22	14.8%	45.3%	US$30.5m	US$33.00	PS3.3x	E-12.2%	n/a
CLNN Clene	US$4.15	1.5%	-53.9%	US$31.0m	US$45.17	PS78.7x	E60.2%	n/a
IBO Impact BioMedical	US$2.75	3.8%	n/a	US$31.4m	n/a	PE27.2x	n/a	n/a
AGE AgeX Therapeutics	US$11.10	-23.6%	-48.7%	US$31.5m	n/a	PS195.5x	n/a	n/a
CTXR Citius Pharmaceuticals	US$3.60	-15.2%	-81.3%	US$32.1m	US$54.00	PB0.3x	E55.3%	n/a
RNXT RenovoRx	US$1.26	5.9%	85.3%	US$32.6m	US$5.25	PB4.3x	E70.9%	n/a
IXHL Incannex Healthcare	US$1.82	-12.9%	-53.1%	US$32.6m	n/a	PS373.4x	n/a	n/a